Sphingolipid-Dependent Protein Kinases

Advances in Pharmacology

Volumn 36, Issue C, 1996, Pages 155-171

  Hakomori, Sen itiroh ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; GANGLIOSIDE; GANGLIOSIDE GM3; GLYCOSPHINGOLIPID; INTEGRIN; PROTEIN TYROSINE KINASE; PSYCHOSINE; SPHINGOSINE;

ANIMAL; CAT; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; INFLAMMATION; METABOLISM; NERVE CELL; PHYSIOLOGY; RABBIT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CATS; G(M3) GANGLIOSIDE; GANGLIOSIDES; GLYCOSPHINGOLIPIDS; INFLAMMATION; INTEGRINS; NEURONS; PROTEIN-TYROSINE KINASES; PSYCHOSINE; RABBITS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 0030358763     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60581-5     Document Type: Article

References (33)

1. Bremer E.G., and Hakomori S. GM3 ganglioside induces hamster fibroblast growth inhibition in chemically-defined medium: Ganglioside may regulate growth factor receptor function. Biochem. Biophys. Res. Commun. 106 (1982) 711-718
2. 3 on tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 261 (1986) 2434-2440
3. Endo K., Igarashi Y., Nisar M., Zhou Q., and Hakomori S. Cell membrane signaling as target in cancer therapy: Inhibitory effect of N,N-dimethyl and N,N,N-trimethyl sphingosine derivatives on in vitro and in vivo growth of human tumor cells in nude mice. Cancer Res. 51 (1991) 1613-1618
4. Hakomori S. Tumor associated carbohydrate antigens. Annu. Rev. Immunol. 2 (1984) 103-126
5. 2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. J. Biol. Chem. 263 (1988) 6296-6301
6. 3 in tyrosine phosphorylation of the epidermal growth factor receptor. J. Biol. Chem. 263 (1988) 10915-10921
7. Hannun Y.A., and Bell R.M. Lysosphingolipids inhibit protein kinase C: Implications for the sphingolipidoses. Science 235 (1987) 670-674
8. Hannun Y.A., Loomis C.R., Merrill Jr. A.H., and Bell R.M. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J. Biol. Chem. 261 (1986) 12604-12609
9. 3, a prominent ganglioside of B16 melanoma. J. Biol. Chem. 260 (1985) 13328-13333
10. Igarashi Y., and Hakomori S. Enzymatic synthesis of N,N-dimethyl-sphingosine: Demonstration of the sphingosine:N-methyltransferase in mouse brain. Biochem. Biophys. Res. Commun. 164 (1989) 1411-1416
11. Igarashi Y., Hakomori S., Toyokuni T., Dean B., Fujita S., Sugimoto M., Ogawa T., El-Ghendy K., and Racker E. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry 28 (1989) 6796-6800
12. Igarashi Y., Nojiri H., Hanai N., and Hakomori S. Gangliosides that modulate membrane protein function. Methods Enzymol. 179 (1989) 521-541
13. Igarashi Y., Kitamura K., Toyokuni T., Dean B., Fenderson B.A., Ogawa T., and Hakomori S. A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation: Demonstration of its endogenous occurrence (and the virtual absence of unsubstituted sphingosine) in human epidermoid carcinoma A431 cells. J. Biol. Chem. 265 (1990) 5385-5389
14. Kojima N., and Hakomori S. Specific interaction between gangliotriaosylceramide (Gg3) and sialosyllactosylceramide (GM3) as a basis for specific cellular recognition between lymphoma and melanoma cells. J. Biol. Chem. 264 (1989) 20159-20162
15. M3-expressing cells based on glycolipid-glycolipid interaction. J. Biol. Chem. 266 (1991) 17552-17558
16. Kolesnick R.N., and Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77 (1994) 325-328
17. Merrill Jr. A.H., Nimkar S., Menaldino D., Hannun Y.A., Loomis C.R., Bell R.M., Tyagi S.R., Lambeth J.D., Stevens V.L., Hunter R., and Liotta D.C. Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds. Biochemistry 28 (1989) 3138-3145
18. Murohara T., Buerke M., Margiotta J., Ruan F., Igarashi Y., Hakomori S., and Lefer A.M. Myocardial and endothelial protection by TMS in ischemia-reperfusion injury. Am. J. Physiol. 269 (1995) H504-H514 (Heart Circ. Physiol. 38)
19. Nojiri H., Stroud M.R., and Hakomori S. A specific type of ganglioside as a modulator of insulin-dependent cell growth and insulin receptor tyrosine kinase activity: Possible association of ganglioside-induced inhibition of insulin receptor function and monocytic differentiation induction in HL60 cells. J. Biol. Chem. 266 (1991) 4531-4537
20. 3 lactone as a possible immunogen: Requirements for tumor-associated antigen and immunogen. J. Immunol. 139 (1987) 3171-3176
21. Nudelman E.D., Levery S.B., Igarashi Y., and Hakomori S. Plasmalopsychosine, a novel plasmal (fatty aldehyde) conjugate of psychosine with cyclic acetal linkage: Isolation and characterization from human brain white matter. J. Biol. Chem. 267 (1992) 11007-11016
22. Okoshi H., Hakomori S., Nisar M., Zhou Q., Kimura S., Tashiro K., and Igarashi Y. Cell membrane signaling as target in cancer therapy II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation. Cancer Res. 51 (1991) 6019-6024
23. Park Y.S., Ruan F., Hakomori S., and Igarashi Y. Cooperative inhibitory effect of N,N,N-trimethylsphingosine and sphingosine-1-phosphate, coincorporated in liposomes, on B16 melanoma cell metastasis: Cell membrane signaling as a target in cancer therapy IV. Int. J. Oncol. 7 (1995) 487-494
24. Sadahira Y., Ruan F., Hakomori S., and Igarashi Y. Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasive-ness. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 9686-9690
25. Sakakura C., Igarashi Y., Anand J.K., Sadozai K.K., and Hakomori S. Plasmalopsychosine of human brain mimics the effect of nerve growth factor by activating its receptor kinase and mitogen-activated protein kinase in PC12 cells: Induction of neurite outgrowth and prevention of apoptosis. J. Biol. Chem. 271 (1996) 946-952
26. Schutze S., Potthoff K., Machleidt T., Berkovic D., Wiegmann K., and Kronke M. TNF activates NF-κB by phosphatidylcholine-specifk phospholi pase C-induced "acidic" sphingomyelin breakdown. Cell 71 (1992) 765-776
27. Sjoberg E.R., Chammas R., Ozawa H., Kawashima I., Khoo K.-H., Morris H.R., Dell A., Tai T., and Varki A. Expression of de-N-acetyl-gangliosides in human melanoma cells is induced by genistein or nocodazole. J. Biol. Chem. 270 (1995) 2921-2930
28. Tsuruoka T., Tsuji T., Nojiri H., Holmes E.H., and Hakomori S. Selection of a mutant cell line based on differential expression of glycosphingolipid, utilizing anti-lactosylceramide antibody and complement. J. Biol. Chem. 268 (1993) 2211-2216
29. Ullrich A., and Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990) 203-212
30. Weis F.M.B., and Davis R.J. Regulation of epidermal growth factor receptor signal transduction: Role of gangliosides. J. Biol. Chem. 265 (1990) 12059-12066
31. Yamakawa T., and Suzuki S. The chemistry of lipids of posthemolytic residue or stroma of erythrocytes: I. Concerning the ether-insoluble lipids of lyophilized horse blood serum. J. Biochem. (Tokyo) 38 (1951) 199-212
32. M3 ganglioside in α5β1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. J. Biol. Chem. 268 (1993) 2217-2222
33. M3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. J. Biol. Chem. 269 (1994) 1959-1965